About Epinex Diagnostics
Epinex Diagnostics is a company based in Tustin (United States) founded in 1997. Epinex Diagnostics has raised $4.5 million across 7 funding rounds. The company has 10 employees as of December 31, 2014. Epinex Diagnostics offers products and services including Epinex G1A Test, Epinex ACR Test, and Epinex SimplySure PT-INR Test. Epinex Diagnostics operates in a competitive market with competitors including SD Biosensor, 1Drop Diagnostics, Nova Biomedical, DiabetOmics and BioHermes, among others.
- Headquarter Tustin, United States
- Employees 10 as on 31 Dec, 2014
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Epinex Diagnostics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.5 M (USD)
in 7 rounds
-
Latest Funding Round
$100 K (USD), Series A
Feb 03, 2016
-
Investors
-
Employee Count
10
as on Dec 31, 2014
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epinex Diagnostics
Epinex Diagnostics offers a comprehensive portfolio of products and services, including Epinex G1A Test, Epinex ACR Test, and Epinex SimplySure PT-INR Test.
Monthly test for diabetes control and monitoring.
Test for albumin and creatinine ratio in urine.
Test for prothrombin time and blood clotting.
People of Epinex Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Epinex Diagnostics
Epinex Diagnostics has successfully raised a total of $4.5M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $100 thousand completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $100,000
-
First Round
First Round
(12 Nov 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2016 | Amount | Series A - Epinex Diagnostics | Valuation |
investors |
|
| Jan, 2016 | Amount | Series A - Epinex Diagnostics | Valuation |
investors |
|
| May, 2014 | Amount | Unspecified - Epinex Diagnostics | Valuation |
investors |
|
Investments & Acquisitions by Epinex Diagnostics
Financial Statements - Epinex Diagnostics
Epinex Diagnostics Comparisons
Competitors of Epinex Diagnostics
Epinex Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, 1Drop Diagnostics, Nova Biomedical, DiabetOmics and BioHermes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| domain | founded_year | HQ Location |
Finger-prick point-of-care diagnostics are provided for biomarker testing.
|
|
| domain | founded_year | HQ Location |
Developer of advanced blood testing analyzers and meters. This company manufactures and sells a wide variety of analyzers for hospital, point-of-care, blood bank, biotechnology, veterinary, and sports medicine applications. Products include blood gas analyzers, glucose meters, lactate meters, and cell culture analyzers. They also offer contract development and manufacturing services for other medical device companies. The analyzers utilize various measurement technologies, including potentiometric, amperometric, and spectrophotometric methods. The company provides complete technical support and product information globally.
|
|
| domain | founded_year | HQ Location |
Point-of-care tests for diabetes and women's health risks are developed.
|
|
| domain | founded_year | HQ Location |
Provider of POC diagnostic devices and kits
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostic products for diabetes and tuberculosis are provided.
|
Latest news on Epinex Diagnostics
Frequently Asked Questions about Epinex Diagnostics
Epinex Diagnostics was founded in 1997 and raised its 1st funding round 12 years after it was founded.
Epinex Diagnostics is headquartered in Tustin, United States. It is registered at Tustin, California, United States.
Epinex Diagnostics is a funded company, having raised a total of $4.5M across 7 funding rounds to date. The company's 1st funding round was a Unspecified of $200K, raised on Nov 12, 2009.
As of Dec 31, 2014, the latest employee count at Epinex Diagnostics is 10.
Epinex Diagnostics was founded in 1997 and is based in Tustin, United States. Medical diagnostics products are developed by the company within the healthcare sector. A point-of-care device named G1A is provided for measuring and analyzing glycated albumin graphically. Wireless integration with patient data systems is supported to store test results. An over-the-counter, palm-sized device is also offered for glycated albumin measurement, functioning similarly to glucose meters.
Epinex Diagnostics's top competitors include SD Biosensor, Nova Biomedical and 1Drop Diagnostics.
Epinex Diagnostics offers Epinex G1A Test, Epinex ACR Test, and Epinex SimplySure PT-INR Test.